"Nail loss after teriflunomide treatment: A new potential adverse event"

Mult Scler Relat Disord. 2017 Nov:18:170-172. doi: 10.1016/j.msard.2017.09.029. Epub 2017 Sep 25.

Abstract

Nail loss might represent a new, reversible, adverse event associated with teriflunomide treatment. It shares close analogies with hair loss and thinning, known adverse events of teriflunomide. MS specialists should be aware of this possibility and evaluate treatment discontinuation.

Keywords: Adverse events; Multiple sclerosis; Nail loss; Teriflunomide; Treatment.

Publication types

  • Case Reports

MeSH terms

  • Crotonates / adverse effects*
  • Crotonates / therapeutic use
  • Female
  • Humans
  • Hydroxybutyrates
  • Immunologic Factors / adverse effects*
  • Immunologic Factors / therapeutic use
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Nail Diseases / chemically induced*
  • Nails / drug effects
  • Nitriles
  • Toluidines / adverse effects*
  • Toluidines / therapeutic use

Substances

  • Crotonates
  • Hydroxybutyrates
  • Immunologic Factors
  • Nitriles
  • Toluidines
  • teriflunomide